prazosin has been researched along with Migraine Disorders in 7 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of ischemia limited to the upper limb caused by chronic use of ergotamine." | 7.71 | Successful treatment of threatening limb loss ischemia of the upper limb caused by ergotamine. A case report and review of the literature. ( Alanezi, KH; Cinà, CS; Safar, HA, 2002) |
| "We report a case of ischemia limited to the upper limb caused by chronic use of ergotamine." | 3.71 | Successful treatment of threatening limb loss ischemia of the upper limb caused by ergotamine. A case report and review of the literature. ( Alanezi, KH; Cinà, CS; Safar, HA, 2002) |
| "A decrease in migraine frequency or severity or both was seen in all but 1 patient, but 5 patients discontinued the drug due to side effects." | 1.30 | Alpha 1-adrenergic blockers: do they have a place in the prophylaxis of migraine? ( Vatz, KA, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobaugh, DS | 1 |
| Paterna, S | 1 |
| Martino, S | 1 |
| Ingurgio, NC | 1 |
| Arrostuto, A | 1 |
| Correo, S | 1 |
| Licata, G | 1 |
| Vatz, KA | 1 |
| Willems, EW | 3 |
| Trion, M | 1 |
| De Vries, P | 2 |
| Heiligers, JP | 2 |
| Villalón, CM | 3 |
| Saxena, PR | 3 |
| Kapoor, K | 1 |
| Tom, B | 1 |
| Valdivia, LF | 1 |
| Safar, HA | 1 |
| Alanezi, KH | 1 |
| Cinà, CS | 1 |
1 trial available for prazosin and Migraine Disorders
| Article | Year |
|---|---|
[The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Chronic Disease; Drug Therapy, Combination; Female; | 1994 |
6 other studies available for prazosin and Migraine Disorders
| Article | Year |
|---|---|
Prazosin treatment of ergotamine-induced peripheral ischemia.
Topics: Adult; Arm; Ergotamine; Female; Humans; Ischemia; Leg; Migraine Disorders; Prazosin; Quinazolines | 1980 |
Alpha 1-adrenergic blockers: do they have a place in the prophylaxis of migraine?
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Child; Doxazosin; Female; Humans; Male; Middle Aged | 1997 |
Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs.
Topics: Anesthesia; Animals; Arteriovenous Anastomosis; Azepines; Carotid Arteries; Hemodynamics; Migraine D | 1999 |
Alpha1-adrenoceptor subtypes mediating vasoconstriction in the carotid circulation of anaesthetized pigs: possible avenues for antimigraine drug development.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Carotid Arteries; Do | 2001 |
Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs.
Topics: Anesthesia; Animals; Carotid Artery, External; Dogs; Hemodynamics; Methylamines; Migraine Disorders; | 2001 |
Successful treatment of threatening limb loss ischemia of the upper limb caused by ergotamine. A case report and review of the literature.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Angiography; Arm; Arterial Occlusive Diseases; E | 2002 |